Hemington Wealth Management Has $1.09 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hemington Wealth Management trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,087 shares of the medical equipment provider’s stock after selling 24 shares during the quarter. Hemington Wealth Management’s holdings in Intuitive Surgical were worth $1,089,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in ISRG. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Sycomore Asset Management raised its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. raised its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $589.61 on Thursday. The company has a market cap of $210.01 billion, a P/E ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39. The stock’s fifty day moving average price is $556.91 and its two-hundred day moving average price is $516.98. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,348 shares of company stock worth $3,587,582. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Barclays boosted their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.